A systematic review and meta-analysis of Nordic walking for chronic heart failure with low left ventricular ejection fraction.

IF 2.2 4区医学 Q1 REHABILITATION

PM&R Pub Date : 2024-08-31 DOI:10.1002/pmrj.13254

Aulia Syavitri Dhamayanti, Rahmad Rahmad, Samiah Rachmawati, Yoga Waranugraha

{"title":"A systematic review and meta-analysis of Nordic walking for chronic heart failure with low left ventricular ejection fraction.","authors":"Aulia Syavitri Dhamayanti, Rahmad Rahmad, Samiah Rachmawati, Yoga Waranugraha","doi":"10.1002/pmrj.13254","DOIUrl":null,"url":null,"abstract":"Background: Nordic walking (NW) has been reported to be beneficial in various chronic diseases.Objective: To determine whether NW improves function in patients with heart failure (HF) with low left ventricular ejection fraction more than conventional cardiac rehabilitation or usual care.Methods: Systematic literature searches in PubMed, ScienceDirect, and Web of Science were conducted. According to patient, intervention, comparison, and outcome (PICO) principles, a stepwise selection process was completed to identify eligible studies. Only randomized controlled trials (RCTs) were included in this systematic review and meta-analysis. Pooled effects were determined using a random effect analysis model for the meta-analysis.Results: A total of 282 participants from four RCTs were included. The improvement of peak oxygen consumption (peak VO2) was greater in the NW group than in the control group (mean difference [MD] = 2.18 mL/kg/min; 95% confidence interval [CI] = 1.35-3.01; p < .01). The improvement of the 6-minute walk test (6MWT) distance was also greater in the NW group than in the control group (MD = 16.51 meters; 95% CI = 3.23-29.80; p = .01).Conclusion: This systematic review highlights the benefits of NW training in patients with chronic HF, particularly those with systolic dysfunction. Specifically, NW walking was associated with increased peak VO2 and 6MWT improvement compared to conventional cardiac rehabilitation or usual care. These results suggest that NW may be a useful component of cardiac rehabilitation. However, additional larger studies with a wider range of patients are needed.","PeriodicalId":20354,"journal":{"name":"PM&R","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PM&R","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pmrj.13254","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"REHABILITATION","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Nordic walking (NW) has been reported to be beneficial in various chronic diseases.

Objective: To determine whether NW improves function in patients with heart failure (HF) with low left ventricular ejection fraction more than conventional cardiac rehabilitation or usual care.

Methods: Systematic literature searches in PubMed, ScienceDirect, and Web of Science were conducted. According to patient, intervention, comparison, and outcome (PICO) principles, a stepwise selection process was completed to identify eligible studies. Only randomized controlled trials (RCTs) were included in this systematic review and meta-analysis. Pooled effects were determined using a random effect analysis model for the meta-analysis.

Results: A total of 282 participants from four RCTs were included. The improvement of peak oxygen consumption (peak VO₂) was greater in the NW group than in the control group (mean difference [MD] = 2.18 mL/kg/min; 95% confidence interval [CI] = 1.35-3.01; p < .01). The improvement of the 6-minute walk test (6MWT) distance was also greater in the NW group than in the control group (MD = 16.51 meters; 95% CI = 3.23-29.80; p = .01).

Conclusion: This systematic review highlights the benefits of NW training in patients with chronic HF, particularly those with systolic dysfunction. Specifically, NW walking was associated with increased peak VO₂ and 6MWT improvement compared to conventional cardiac rehabilitation or usual care. These results suggest that NW may be a useful component of cardiac rehabilitation. However, additional larger studies with a wider range of patients are needed.

查看原文本刊更多论文

北欧式健走治疗左心室射血分数低的慢性心力衰竭的系统回顾和荟萃分析。

背景：据报道，北欧式行走（NW）对多种慢性疾病有益：据报道，北欧式行走（NW）对多种慢性疾病有益：目的：确定北欧式行走对左心室射血分数低的心力衰竭（HF）患者的功能改善是否优于传统的心脏康复或常规护理：方法：在 PubMed、ScienceDirect 和 Web of Science 中进行了系统的文献检索。根据患者、干预、比较和结果（PICO）原则，完成了逐步筛选过程，以确定符合条件的研究。本系统综述和荟萃分析只纳入了随机对照试验（RCT）。荟萃分析采用随机效应分析模型确定汇总效应：结果：共纳入了四项研究中的 282 名参与者。NW组的峰值耗氧量（peak VO2）改善幅度大于对照组（平均差异[MD] = 2.18 mL/kg/min；95%置信区间[CI] = 1.35-3.01；P 结论：这篇系统综述强调了NW疗法的益处：本系统综述强调了负重行走训练对慢性心房颤动患者，尤其是收缩功能障碍患者的益处。具体而言，与传统的心脏康复或常规护理相比，NW 步行与峰值 VO2 的增加和 6MWT 的改善相关。这些结果表明，负重行走可能是心脏康复的一个有用组成部分。不过，还需要对更多患者进行更大规模的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PM&R REHABILITATION-SPORT SCIENCES

CiteScore

4.30

自引率

4.80%

发文量

187

审稿时长

4-8 weeks

期刊介绍： Topics covered include acute and chronic musculoskeletal disorders and pain, neurologic conditions involving the central and peripheral nervous systems, rehabilitation of impairments associated with disabilities in adults and children, and neurophysiology and electrodiagnosis. PM&R emphasizes principles of injury, function, and rehabilitation, and is designed to be relevant to practitioners and researchers in a variety of medical and surgical specialties and rehabilitation disciplines including allied health.